[ January 24, 2011 ]
DNDi-Cipla & Vimal’s Symposium - Artemisinin Combination
Therapy (ACTs) in Myanmar: Status update and outlook
Yangon, Myanmar
Drugs for Neglected Diseases initiative (DNDi) and Cipla, jointly with Vimal,
organise a symposium to discuss the use of Artemisin Combination Therapy
in Myanmar.
click here to read more

[November 3-7, 2010]
ASTMH 2010 – Atlanta, USA
The Drugs for Neglected Diseases initiative (DNDi) participates at ASTMH 2010 with
several activities, amongst which a joint symposium with Central Drug Research Institute (CDRI)
on Visheral Leishmaniasis (VL) in the Indian Continent, a second symposium on VL in East Africa,
a satellite symposium on Challenges and Successes of the FACT Project through Innovative
Partnerships for the development of Artesunate Combination Therapies for Malaria, as well as
several oral presentations.
click here to read more

[November 18-22, 2009]
ASTMH 2009 – Washington DC, USA
The Drugs for Neglected Diseases initiative (DNDi) participates at ASTMH 2009 with
several activities, among a joint symposium with sanofi-aventis on Pharmacovigilance
of new anti-malarials in the field, a satelllite symposium on ASMQ, the anti-malarial
Fixed-Dose Combination of Artesunate-Mefloquine, as well as several oral
presentations and posters.
click here to read more

[ April 2008 ]
ASMQ Launch - Rio de Janeiro  
Farmanguinhos/Fiocruz and DNDi launched ASMQ, the new fixed-dose combination of artesunate (AS) and mefloquine (MQ), now registered in Brazil. Developed and delivered by a worldwide collaboration of public partners, ASMQ will soon be available throughout Latin American and Southeast Asia.
Click here to read more

[ November 2007 ]
56th American Society of Tropical Medicine and Hygiene
(ASTMH) - Philadelphia, USA / DNDi's Symposium on ACT
Sanofi-aventis and DNDi held a symposium about the implementation of a new artemisinin
combination therapy (ACT) in African endemic countries. Over 120 attendees from NGOs,
academia, and the pharmaceutical sector were an audience to FACT project partners’
presentations on ASAQ and ASMQ. Besides that, DNDi also presented on the ethical
considerations of malaria field studies, and on the screening of natural products against
infectious disease pathogens.
click here to read more